$448.38 -5.62 (%) Regeneron Pharmaceuticals Inc - NASDAQ

Mar. 26, 2015 | 04:00 PM

Partner Headlines

  1. Can These Three BioTech Companies Make It Big?

    GuruFocus | Feb. 20, 2015 | 15:22PM EST
  2. Bernstein Initiates Regeneron Pharmaceuticals At Outperform

    Benzinga | Feb. 17, 2015 | 08:04AM EST
  3. Regeneron's Expanded Pipeline Not A Concern For Morgan Stanley

    Benzinga | Feb. 11, 2015 | 10:26AM EST
  4. Regeneron Guidance Strong

    IBD | Feb. 10, 2015 | 18:46PM EST
  5. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD | Feb. 10, 2015 | 10:30AM EST
  6. UPDATE: Regeneron Pharmaceuticals Posts Downbeat Q4 Earnings, But Sales Top Views

    Benzinga | Feb. 10, 2015 | 09:24AM EST
  7. Earnings Scheduled For February 10, 2015

    Benzinga | Feb. 10, 2015 | 04:42AM EST
  8. 2 Hot Medical Stocks Report Earnings On Tuesday

    IBD | Feb. 9, 2015 | 15:50PM EST
  9. Energy Stocks Lead Mutual Funds' Dive Into Red In Jan.

    IBD | Feb. 3, 2015 | 18:22PM EST
  10. How To Trade Stocks: Shaken Out? You Can Get Back In

    IBD | Jan. 29, 2015 | 17:43PM EST
  11. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Jan. 26, 2015 | 07:14AM EST
  12. The 5 Biggest Biotech Stocks

    Benzinga | Jan. 20, 2015 | 16:43PM EST
  13. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  14. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  15. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  16. Regeneron rises on drug data

    IBD | Jan. 9, 2015 | 18:42PM EST
  17. Regeneron Jumps On Favorable Cholesterol Drug Report

    IBD | Jan. 9, 2015 | 15:42PM EST
  18. Indexes Slump As Employment Data, Falling Oil Weigh

    IBD | Jan. 9, 2015 | 15:13PM EST
  19. Stocks Stay In Red; Acuity Soars On Strong LED Demand

    IBD | Jan. 9, 2015 | 13:29PM EST
  20. Stocks Reverse Lower On Good News/Bad News Job Data

    IBD | Jan. 9, 2015 | 11:52AM EST
  21. Drugs May Be Blockbusters

    IBD | Jan. 8, 2015 | 18:54PM EST
  22. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  23. J.P. Morgan Chimes In With Ratings On BioTech Stocks

    GuruFocus | Jan. 6, 2015 | 12:46PM EST
  24. UPDATE: Barclays Initiates Coverage On Regeneron

    Benzinga | Jan. 6, 2015 | 11:28AM EST
  25. Morgan Stanley Issues Wave Of Pharma & Medical Device Upgrades, Downgrades

    Benzinga | Jan. 5, 2015 | 15:57PM EST
  26. Nasdaq, Russell 2000 Join New-High Party; GoPro Up Again

    IBD | Dec. 26, 2014 | 16:16PM EST
  27. Tesla Motors Up On Battery News; Stocks At Record

    IBD | Dec. 26, 2014 | 15:07PM EST
  28. Fresh Milestones For Dow, S&P 500 But Biotechs Hit

    IBD | Dec. 23, 2014 | 14:48PM EST
  29. Dow Crosses 18,000 But Medical-Related Groups Fall Hard

    IBD | Dec. 23, 2014 | 13:22PM EST
  30. Making Money With Charles Payne: 12/22/14

    FoxBusiness | Dec. 22, 2014 | 18:00PM EST
  31. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD | Dec. 22, 2014 | 10:34AM EST
  32. Stocks Hit By More Selling; S&P 500 Gives Up 50-Day Line

    IBD | Dec. 15, 2014 | 14:53PM EST
  33. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  34. Stocks Fall To Session Lows: GoPro Gives Up More Ground

    IBD | Dec. 8, 2014 | 13:25PM EST
  35. A Look At 3 Overbought ETFs

    Benzinga | Dec. 2, 2014 | 17:34PM EST
  36. EYLEA Injection Accepted For Priority Review By FDA For Diabetic Retinopathy In Patients With Diabetic Macular Edema

    Benzinga | Dec. 1, 2014 | 07:02AM EST
  37. Weekly Insider Sells Highlight: REGN, HSP, TYC, AAPL

    GuruFocus | Nov. 30, 2014 | 14:00PM EST
  38. Alibaba Among 5 Top Stocks With Top Profit Margins

    IBD | Nov. 23, 2014 | 08:10AM EST
  39. UPDATE: Bank Of America Reiterates On Regeneron Pharmaceuticals Following Several Positive Catalysts

    Benzinga | Nov. 21, 2014 | 10:24AM EST
  40. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD | Nov. 20, 2014 | 11:44AM EST
  41. UPDATE: Brean Capital Reiterates On Regeneron Pharmaceuticals On Increased Confidence

    Benzinga | Nov. 20, 2014 | 09:08AM EST
  42. US Stock Futures Mostly Flat Ahead Of Housing Data

    Benzinga | Nov. 18, 2014 | 07:11AM EST
  43. Merck Drug Works: Vytorin Study Proves Successful

    IBD | Nov. 17, 2014 | 13:35PM EST
  44. Meet 5 U.S. Techs, Biotechs With Strong Fundamentals

    IBD | Nov. 13, 2014 | 08:02AM EST
  45. Asthma treatment passes trial

    IBD | Nov. 11, 2014 | 18:30PM EST
  46. Regeneron Misses Q3 Views

    IBD | Nov. 5, 2014 | 13:07PM EST
  47. Jazz Beats And Raises Views; Regeneron Misses In Q3

    IBD | Nov. 4, 2014 | 19:02PM EST
  48. Regeneron Q3 Earnings Miss As U.S. Eylea Sales Falter

    IBD | Nov. 4, 2014 | 10:51AM EST
  49. Stocks Tightly Mixed After Open; Alibaba Climbs On Q2 Results

    IBD | Nov. 4, 2014 | 10:32AM EST
  50. Morning Market Losers

    Benzinga | Nov. 4, 2014 | 09:58AM EST
Trading Center